CAS 919797-19-6
| 25I-NBOMe Basic information |
| Product Name: | 25I-NBOMe |
| Synonyms: | 2C-I-NBOMe;4-Iodo-2,5-diMethoxy-N-[(2-Methoxyphenyl)Methyl];N-(2-methoxybenzyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethanamine;4-Iodo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]benzeneethanamine;2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine;Benzeneethanamine, 4-iodo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]- |
| CAS: | 919797-19-6 |
| MF: | C18H22INO3 |
| MW: | 427.28 |
| EINECS: | |
| Product Categories: | research chemical;Amines;Aromatics;Intermediates & Fine Chemicals;Pharmaceuticals |
| Mol File: | 919797-19-6.mol |
![]() |
|
| 25I-NBOMe Chemical Properties |
| Boiling point | 480.4±45.0 °C(Predicted) |
| density | 1.413 |
| pka | 8.91±0.20(Predicted) |
| Safety Information |
| 25I-NBOMe Usage And Synthesis |
| Uses | 25I-NBOMe is a derivative of the phenethylamine hallucinogen 2C-I (D470000), discovered in 2003. 25I-NBOMe acts as a highly potent agonist for the human 5-HT2A receptor. The drug is not active orally and must be taken buccally, sublingually or intranasally. This product can only be used for chemical research. |
